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Severe acute respiratory syndrome (SARS) is an
emerging viral infectious disease. One of the largest out-
breaks of SARS to date began in Singapore in March 2003.
We describe the clinical, laboratory, and radiologic features
of the index patient and the patient’s initial contacts affect-
ed with probable SARS. 
S
evere acute respiratory syndrome (SARS), an atypical
pneumonia characterized by high rate of transmission
to healthcare workers (1), began in Guangdong Province,
China, in November 2002. One of the largest SARS out-
breaks to date began in Singapore in mid-March 2003 and
was traced to a traveler returning from Hong Kong. 
According to the World Health Organization, a suspect-
ed case of SARS is defined as documented fever (temper-
ature >38°C), lower respiratory tract symptoms, and con-
tact with a person believed to have had SARS or history of
travel to an area of documented transmission. A probable
case is a suspected case with chest radiographic findings of
pneumonia, acute respiratory distress syndrome (ARDS),
or an unexplained respiratory illness resulting in death,
with autopsy findings of ARDS without identifiable cause
(2). We describe the clinical features of the index patient in
Singapore and the patient’s initial group of contacts affect-
ed with probable SARS.
The Index Case 
The index case of SARS in Singapore ocurred in a pre-
viously healthy 23-year-old woman of Chinese ethnicity
who had stayed on the 9th floor of a hotel during a vaca-
tion to Hong Kong, February 20–25, 2003. A physician
from southern China who stayed on the same floor of the
hotel during this period is believed to have been the source
of infection for this index patient and the index patients of
outbreaks in Vietnam and Canada. 
Fever and headache developed in the patient on
February 25 and a dry cough on February 28. She was
admitted to Tan Tock Seng Hospital, Singapore, on March
1. On admission she had oral temperature of 37.6°C and
was lethargic. The chest was clear to auscultation. The
remainder of her physical examination was normal. The
total leukocyte count (2.7 × 10
9/L), lymphocyte count (0.9
× 10
9/L), and platelet count (102 × 10
9/L) were reduced
below normal laboratory ranges. Electrolytes and liver bio-
chemistry results were normal. The chest x-ray showed
patchy consolidation of both upper and lower lobes of her
right lung (Figure 1a). Blood cultures were sterile, and
tests for urinary Legionella antigen, particle agglutination
test for Mycoplasma pneumoniae antibodies, and comple-
ment fixation test for Chlamydia antibodies were negative.
Immunofluorescence performed on nasopharyngeal aspi-
rates for viral antigens of influenza virus A and B, parain-
fluenza virus, respiratory syncytial virus, and adenovirus
was negative. 
Intravenous levofloxacin, 500 mg once a day, was
administered, but the patient’s temperature continued to
spike up to 40°C, and the cough persisted. On day 5 of hos-
pitalization, she became breathless and required supple-
mental oxygen. Sequential chest x-rays showed progres-
sive, extensive involvement of the right lung, with new
infiltrates appearing on the left (Figure 1c). Liver enzymes
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Figure 1. Chest radiographs of index patient with severe acute res-
piratory syndrome (SARS). a, day 5 of symptoms; b, day 10; c, day
13; d, day 15.became elevated, with an ALT of 200 U/L (7–36 U/L) and
AST of 208 U/L (15–33 U/L); serum lactate dehydroge-
nase (LDH) levels rose to 1518 U/L (200–500 U/L).
Intravenous vancomycin (1 g twice a day) and oral
oseltamivir (75 mg twice a day) were added to the regi-
men. Nine days after admission, the patient began to
improve clinically, the laboratory abnormalities returned
towards normal, and the chest x-ray abnormalities stabi-
lized and resolved. The patient has remained well. 
Electron microscopy of the specimens obtained by
nasopharyngeal aspiration on day 7 of hospitalization
showed viral particles of <100 nm with widely spaced,
club-shaped surface projections characteristic of coron-
aviruses.
Clinical Features of Contact Cases
When the index patient was seen in early March, the
clinical features and highly infectious nature of SARS
were not known. For the first 6 days of hospitalization, the
patient was in a general ward, without barrier infection
control measures. One of eight physicians who attended
her became infected, as did 9 of approximately 30 nursing
staff. SARS also developed in 1 of 12 patients in adjacent
beds during her hospitalization and 9 of approximately 30
family members and friends who visited her during this
time. Nineteen of these 20 patients were admitted to our
hospital for treatment and isolation (1 was treated outside
Singapore), and we recorded prospectively the clinical fea-
tures of their illnesses with a standardized data collection
form. In addition to demographic data, this form elicited
information on occupation, date(s) of exposure to suspect-
ed cases, travel history after February 20, dates of onset of
various symptoms, results of blood tests, and chest radi-
ographic findings.
The demographic profiles of the index and 19 contact
cases are shown (Table 1). An epidemic curve of the index
and contact cases is shown in Figure 2. Because most
healthcare staff in our hospital are women, a high propor-
tion of the case-patients (75%) were female. The median
age of patients was 28 years. All were previously healthy,
except one who had diabetes mellitus and end-stage renal
failure and one who had a history of childhood asthma. One
patient was a smoker. For seven patients who only had one
exposure to the index patient, the median incubation period
was 4 days (estimated range 2–8 days). For those with mul-
tiple exposures (13 patients), median incubation period was
either 7 days (range 4–12 days, calculated from day 1 of
exposure), or 5 days (range 3–9 days, calculated from mid-
point of exposure period). The median period from onset of
symptoms to admission was 6 days (range 0–9 days)
At admission, all patients had fever, sometimes accom-
panied by myalgia and headache (Table 2). Other symp-
toms, including dry cough, developed 2–4 days after onset
of fever. Shortness of breath (when present) generally
manifested in week 2 of illness. Apart from elevated tem-
perature, results of physical examination were generally
normal. The paucity of lung findings was often in striking
contrast to the florid chest radiographic changes.
Laboratory investigations at admission are shown
(Table 3). Lymphopenia, as defined by a cell count of <1.5
x 109/L, was present in 18 of 20 patients. Other common
laboratory abnormalities included leukopenia, thrombocy-
topenia, elevated LDH, mild hyponatremia, mild
hypokalemia, and raised hepatic transaminases. 
Abnormal chest radiographs were seen in 14 patients at
admission. Abnormalities developed in the remaining six
patients by day 11 of illness. The most common pattern
noted initially was interstitial infiltrates at the base of the
right lung (11/20 patients). Right upper lobe infiltrates
were seen in four patients, and involvement of both right
upper and lower lobes was seen in three. One patient each
had left lower lobe and bibasal infiltrates. Radiographic
abnormalities rapidly progressed in all but one patient, and
an ARDS-type picture developed in six patients, who sub-
sequently required mechanical ventilation (Figures 1, 3). 
Results of routine microbiologic cultures, serologic
tests, and rapid antigen tests were universally negative.
However, viral particles characteristic of coronavirus were
found on electron microscopy examination of nasopharyn-
geal aspirates in 4 of 10 patients. 
The clinical course of the illness is shown (Table 4). In
11 patients, oxygen saturation fell below 95%, and supple-
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Table 1. Demographic description of patients with severe acute 
respiratory syndrome, Singapore 
Demographics  No. 
No. of men (%)
a  5 (25) 
No. of healthcare workers (%)
a  9 (45) 
Median age in years (range)  28 (19–73) 
Median days from onset of symptoms to 
admission (range) 
6.0 (0–9) 
aN=20. 
 
Figure 2. Index and contact cases of severe acute respiratory syn-
drome (SARS), by date of symptom onset.mental oxygen was instituted. Of these patients, six subse-
quently required mechanical ventilation for worsening res-
piratory failure. Clinical deterioration generally occurred
in week 2 of illness.
All patients were initially treated with either lev-
ofloxacin or a combination of intravenous ceftriaxone and
a macrolide once x-ray abnormalities were observed.
Oseltamivir, 75 mg twice a day, and oral ribavirin, 20
mg/kg body weight three times a day, were prescribed to 6
and 14 patients, respectively. These antiviral drugs were
started late in the course of illness: Most were prescribed
from day 10 to day 14 of symptoms. Five patients in the
intensive care unit were given corticosteroids (intravenous
hydrocortisone, 100 mg every 6 hours, or intravenous
methylprednisolone, 120 mg once a day). 
Patients with ARDS were supported aggressively with
intubation and mechanical, pressure-controlled ventilation
with high positive end-expiratory pressures. Despite these
and other supportive measures, three patients died of pro-
gressive respiratory failure.
Fever and laboratory and radiologic abnormalities
resolved beginning from day 10 of illness. Patients with
milder disease improved earlier. Of six patients who
required mechanical ventilation, three died, and two
improved sufficiently to be extubated. The last patient
remains critically ill at the time of writing. 
Conclusions
Initial clinical features of SARS are nonspecific. Dry
cough is common, although other symptoms of upper res-
piratory tract infection are unusual. Physical signs on chest
examination are minimal, and chest radiograph may be
normal on week 1 of illness. Laboratory tests often show
lymphopenia, mild thrombocytopenia, and elevated liver
enzymes. Therefore, in early stages, SARS may be hard to
differentiate from other viral infections, and diagnostic
delays may contribute to the spread of the epidemic. Early
diagnosis relies on known history of potential exposure to
SARS. Clinicians must maintain a high index of suspicion
and be familiar with the rapidly changing epidemiology of
this infection. Early diagnosis minimizes transmission.
In this initial cohort, radiologic changes eventually
developed in all contacts with fever. However, the extent
of chest x-ray changes and respiratory failure varied wide-
ly, and subsequent observations suggest a milder form of
illness in which radiologic changes are not apparent.
Whether asymptomatic infection can occur is unknown,
but a more comprehensive description of the spectrum of
clinical illness will only be possible when a diagnostic test
is available. To this end, we are collecting serum from
healthcare staff exposed to SARS patients.
The index patient infected at least 20 others over a peri-
od of several days. These cases were probably secondary
rather than tertiary because the dates of symptom onset
were very close and little interaction occurred between
contacts. Patient 20 had a relatively late onset, but she was
discharged from our hospital by March 6 and had no sub-
sequent contact with other case-patients. Clearly, this
infection is highly transmissible from person to person,
and healthcare workers are particularly at risk (3–5). The
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Table 2. Clinical features of severe acute respiratory syndrome 
Symptom  No. (%) (N=20) 
Fever  20 (100) 
Dry cough  15 (75) 
Myalgia  9 (45) 
Malaise  9 (45) 
Anorexia  9 (45) 
Shortness of breath  8 (40) 
Nausea/ vomiting  7 (35) 
Sore throat  5 (25) 
Diarrhea  5 (25) 
Headache  4 (20) 
Chills and rigors  3 (15) 
Rhinorrhea  3 (15) 
 
Figure 3. Chest radiographs of two patients with severe acute res-
piratory syndrome (SARS). a–c: radiographs of patient 5 showing
progression of changes. a, day 8 of symptoms; b, day 13 of symp-
toms, c, day 14 of symptoms. He died on day 19 of this illness. d,
chest radiograph, taken on day 8 of symptoms, of patient 12, with
right upper lobe infiltrates resembling pulmonary tuberculosis (TB)
but laryngeal swab cultures for TB were negative.precise routes of transmission in a healthcare setting need
to be defined, although the predominance of right lower
lobe findings on chest radiography suggests that droplet or
airborne transmission is involved. However, were airborne
transmission involved, we would have seen a much greater
number of cases with weaker contact links to the index
patient. We did not see any further transmission from this
index patient after we implemented strict infection control
measures involving use of N95 masks, gown, gloves, and
handwashing before and after patient contact. Which com-
ponents of this approach are responsible for the decrease in
transmission is unclear. 
Acoronavirus was identified on electron microscopy of
nasopharyngeal aspirates in our index patient and several
of her contacts and is therefore likely to be responsible for
this outbreak. This finding concurs with those in SARS
outbreaks in other countries (6). Coronaviruses are wide-
spread in the animal kingdom, and human coronaviruses
are one of the main causes of the common cold. These
viruses are also an important cause of pneumonia in mili-
tary recruits (7). The aggressive nature of this disease sug-
gests a new variant coronavirus; preliminary studies (3–5)
confirm this hypothesis. 
No effective treatment is known for this infection. We
did not observe any obvious response to antibiotic therapy.
However, until a specific diagnostic test is widely avail-
able, physicians should consider the use of empiric antibi-
otic therapy, including for atypical organisms in cases of
probable SARS in which bacterial pneumonia cannot be
definitely excluded. 
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Table 3. Summary of severe acute respiratory syndrome signs and laboratory tests done at admission, Singapore, 2003 
Test  Mean (SD)  Median (range) 
Temperature (°C)  38.3 (0.9)  38.4 (37–40) 
Oxygen saturation (%)  97.9 (1.8)  98 (92–100) 
Leukocytes (4–10 x10
9/L)  4.8 (2.2)  4.2 (2.5–10.6) 
Lymphocytes (1.5–4.3 x10
9/L)  0.9 (0.4)  0.7 (0.5–1.7) 
Platelet count (160–390 x 10
9/L)  159 (48.3)  151 (98–272) 
Alanine aminotransferase (7–36 U/L)  40.6 (78)  17 (7–355) 
Lactate dehydrogenase (200–500 U/L)  532.2 (260)  432 (306–1142) 
Albumin (40–50 g/L)  38.6 (5.1)  39 (25–46) 
Globulin (25–40 g/L)  33.9 (4.6)  35 (25–45) 
Urea (2–7.5 mmol/L)
a  3.2 (1.5)  2.9 (1.9–8.5) 
Creatinine (25–100 umol/L)
a  65.4 (12.4)  65 (39–88) 
Sodium (135–145 mmol/L)
a  134.9 (2.8)  135 (131–141) 
Potassium (3.5–5.0 mmol/L)
a  3.5 (0.3)  3.6 (2.8–4) 
aThe laboratory results of patient 20, who had end-stage renal failure, were not included in this table. 
Table 4. Clinical course of severe acute respiratory syndrome (days after onset of symptoms) occurring up to April 10, 2003 
Patient  Sex
a  Age  Date of onset 
Admission 
to hospital 
First 
abnormal 
chest x-ray 
Supplemental 
oxygen 
requirement 
Mechanical 
ventilation 
Fever 
resolved 
Radiologic 
improvement 
(Death)/ 
medically fit 
for discharge 
1 (Index)  F  23  February 25  5  5  13  Not required  18  15  20 
2  F  45  March 4  9  9  13  13  22  20  Hospitalized 
3  F  46  March 5  6  6  11  13  Not seen  Not seen  (34) 
4  M  25  March 6  9  9  Not required  Not required  12  14  19 
5  M  50  March 7  8  8  8  10  Not seen  Not seen  (19) 
6  F  27  March 7  5  8  Not required  Not required  16  16  21 
7  F  23  March 7  5  5  Not required  Not required  10  13  15 
8  M  40  March 7  6  6  8  10  Not seen  Not seen  (20) 
9  F  28  March 8  7  9  Not required  Not required  11  12  13 
10  F  26  March 8  7  7  11  Not required  14  14  17 
11  M  27  March 9  8  8  Not required  Not required  12  14  17 
12  M  39  March 9  7  11  Not required  Not required  13  15  18 
13  F  19  March 9  7  7  13  Not required  20  17  23 
14  F  73  March 9  7  7  10  11  12  18  20 
15  F  23  March 9  6  6  11  Not required  16  16  19 
16  F  35  March 9  0  9  Not required  Not required  11  12  13 
17  F  22  March 10  7  11  Not required  Not required  13  14  17 
18  F  30  March 10  5  9  Not required  Not required  11  14  15 
19  F  22  March1 1  4  4  8  Not required  10  13  14 
20  F  42  March 14  4  4  4  5  9  10  Hospitalized 
aF, female; M, male. Steroids were prescribed for five of six patients who
had ARDS and were on mechanical ventilation. No per-
ceived benefits accrued from this practice, although small-
er doses were used than in Hong Kong (4,5).
A number of our patients received ribavirin, a broad-
spectrum antiviral drug with known activity against some
RNA viruses. However, we did not observe any obvious
response to this drug, and several patients deteriorated in
spite of its use. In contrast, a number of patients (including
our index patient) recovered without use of ribavirin.
Although some anecdotal reports of efficacy of ribavirin
(when used in conjunction with steroids) exist (4,5), its
efficacy is hard to judge for a condition that has potential
for spontaneous recovery. Evidence from randomized con-
trolled trials is needed before the use of ribavirin can be
advocated for routine use in SARS patients. 
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